These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4758387)

  • 1. A study of methods for producing cell-free tumour antigen from BP8 mouse ascites tumour.
    Davies EG; Cater DB
    Br J Exp Pathol; 1973 Oct; 54(5):583-9. PubMed ID: 4758387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of murine tumor-associated antigens by the micro-leukocyte adherence inhibition assay.
    Howell JH; Russo AJ; Goldrosen MH
    Cancer Res; 1979 Feb; 39(2 Pt 2):612-8. PubMed ID: 83914
    [No Abstract]   [Full Text] [Related]  

  • 3. Separation of a tumour specific transplantation-type antigen from the ascitic fluid of mice bearing a syngeneic lymphoma.
    Wolf A; Steele KA
    Br J Cancer; 1975 Jun; 31(6):684-8. PubMed ID: 1174446
    [No Abstract]   [Full Text] [Related]  

  • 4. Oncogenicity and immunogenicity associated with membranes isolated from cell-free ascites fluid of lymphoma-bearing mice.
    Raz A; Barzilai R; Spira G; Inbar M
    Cancer Res; 1978 Aug; 38(8):2480-5. PubMed ID: 667843
    [No Abstract]   [Full Text] [Related]  

  • 5. The combined effects of x-rays and cell-borne immunity on cells of the C3H mouse tumour BP8, studied in vitro by a terminal dilution technique.
    Munro TR; Porteous DD
    Br J Radiol; 1972 Oct; 45(538):793. PubMed ID: 4672983
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of tumour-associated transplantation antigen of BO-IV carcinoma on somatic cells of tumour-free syngeneic mice. 3. Demonstration of this antigen on the lymphoreticular system of adult mice.
    Rejthar A; Wotke J
    Folia Biol (Praha); 1974; 20(4):244-51. PubMed ID: 4472054
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody response to ATPC+ascites tumour in mice rendered resistant by intravenous inoculation of liver cells.
    Pitzurra M; Marconi P
    Boll Ist Sieroter Milan; 1972; 51(5):393-404. PubMed ID: 4656954
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary antibody formation in vitro by mouse cells in a complete homologous system.
    Munder PG; Modolell M; Raetz W; Luckenbach GA
    Eur J Immunol; 1973 Jul; 3(7):454-7. PubMed ID: 4796634
    [No Abstract]   [Full Text] [Related]  

  • 9. BCG-induced murine effector cells. I. Cytolytic activity in peritoneal exudates: an early response to BCG.
    Tracey DE; Wolfe SA; Durdik JM; Henney CS
    J Immunol; 1977 Sep; 119(3):1145-51. PubMed ID: 330748
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence for related antigens on sperm, tumor, and fetal cells in the mouse.
    Goldberg EH; Tokuda S
    Transplant Proc; 1977 Jun; 9(2):1363-5. PubMed ID: 878010
    [No Abstract]   [Full Text] [Related]  

  • 11. The immune recognition of TA3 tumors, its facilitation by endotoxin, and abrogation by ascites fluid.
    Grohsman J; Nowotny A
    J Immunol; 1972 Nov; 109(5):1090-5. PubMed ID: 4562425
    [No Abstract]   [Full Text] [Related]  

  • 12. [Production of a cytotoxic factor in mouse peritoneal fluid by OK-432, a streptococcal preparation].
    Yamamoto A; Nagamuta M; Usami H; Sugawara Y; Watanabe N; Niitsu Y; Urushizaki I
    Gan To Kagaku Ryoho; 1986 May; 13(5):1905-10. PubMed ID: 3707150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal by peritoneal adherent cells of tumor cell suppression of T cell-mediated immunity.
    Ting CC; Rodrigues D
    J Immunol; 1979 Aug; 123(2):801-7. PubMed ID: 156764
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of synergy between cyclophosphamide therapy and immunity against a mouse tumour.
    Chassoux DM; Gotch FM; MacLennan IC
    Br J Cancer; 1978 Aug; 38(2):211-8. PubMed ID: 698035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-reactivity of incompatible lymphoid cells from f1 modified radiation chimeras to host tumour cells in vitro.
    Grant CK; Ilbery PL
    Biomedicine; 1973 Feb; 19(2):56-60. PubMed ID: 4581503
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of lymphocyte trapping by cell-free ascitic fluids cultivated in syngeneic mice.
    Mongini PK; Rosenberg LT
    J Immunol; 1975 Feb; 114(2 Pt 1):650-4. PubMed ID: 1120902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune RNA-mediated transfer of tumor antigen responsiveness to unresponsive peritoneal exudate cells from tumor-bearing animals.
    Braun DP; Dray S
    Cancer Res; 1977 Nov; 37(11):4138-44. PubMed ID: 908048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression of alloantigens in malignancy. Evidence for tumour susceptibility alloantigens and for possible self-reactivity of lymphoid cells active in the microcytotoxicity assay.
    Martin WJ; Esber E; Cotton WG; Rice JM
    Br J Cancer Suppl; 1973 Aug; 1():48-61. PubMed ID: 4804290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticomplement activity of the serum, ascitic fluid and tumor fluid of animals with transplantable experimental neoplasms. Cytotoxic activity of the antibodies].
    Valguarnera G
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):1013-6. PubMed ID: 4463978
    [No Abstract]   [Full Text] [Related]  

  • 20. In-vitro and in-vivo adherence of allergised lymph-node cells to BP8 ascites tumour cells, in the presence of polyamines and quarternary ammonium compounds.
    Crocker J; Cater DB
    J Pathol; 1973 Apr; 109(4):323-34. PubMed ID: 4720913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.